ScinoPharm Taiwan, Ltd. (TPE:1789)
Taiwan
· Delayed Price · Currency is TWD 20.80
+0.20 (0.97%)
Mar 10, 2026, 11:09 AM CST
ScinoPharm Taiwan Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 16,289 | 13,245 | 17,436 | 20,876 | 20,124 | 19,492 | Upgrade
|
| Market Cap Growth | -8.65% | -24.04% | -16.48% | 3.73% | 3.25% | -14.56% | Upgrade
|
| Enterprise Value | 13,942 | 11,170 | 14,136 | 17,530 | 16,527 | 16,275 | Upgrade
|
| Last Close Price | 20.60 | 16.75 | 21.60 | 25.60 | 24.37 | 23.17 | Upgrade
|
| PE Ratio | 121.18 | 96.71 | 51.38 | 72.72 | 56.98 | 80.06 | Upgrade
|
| Forward PE | 51.50 | 108.27 | 108.27 | 102.52 | 52.60 | 36.38 | Upgrade
|
| PS Ratio | 5.15 | 4.19 | 5.12 | 6.55 | 6.17 | 7.06 | Upgrade
|
| PB Ratio | 1.55 | 1.26 | 1.66 | 2.01 | 1.93 | 1.85 | Upgrade
|
| P/TBV Ratio | 1.55 | 1.26 | 1.66 | 2.02 | 1.93 | 1.86 | Upgrade
|
| P/FCF Ratio | 53.47 | 43.48 | 37.04 | - | 37.93 | 99.76 | Upgrade
|
| P/OCF Ratio | 27.34 | 22.23 | 23.22 | 90.32 | 26.01 | 38.23 | Upgrade
|
| EV/Sales Ratio | 4.41 | 3.53 | 4.15 | 5.50 | 5.06 | 5.89 | Upgrade
|
| EV/EBITDA Ratio | 22.28 | 17.85 | 17.85 | 23.07 | 19.93 | 24.83 | Upgrade
|
| EV/EBIT Ratio | 128.02 | 102.57 | 44.03 | 55.74 | 40.76 | 56.39 | Upgrade
|
| EV/FCF Ratio | 45.77 | 36.67 | 30.03 | - | 31.15 | 83.29 | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.07 | 0.06 | 0.06 | 0.07 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | 1.22 | 1.22 | 0.83 | 0.80 | 0.80 | 0.83 | Upgrade
|
| Debt / FCF Ratio | 2.50 | 2.50 | 1.44 | - | 1.28 | 2.85 | Upgrade
|
| Net Debt / Equity Ratio | -0.22 | -0.22 | -0.33 | -0.32 | -0.35 | -0.33 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.75 | -3.75 | -4.41 | -4.37 | -4.36 | -5.38 | Upgrade
|
| Net Debt / FCF Ratio | -7.71 | -7.71 | -7.41 | 89.04 | -6.82 | -18.04 | Upgrade
|
| Asset Turnover | 0.27 | 0.27 | 0.29 | 0.27 | 0.28 | 0.24 | Upgrade
|
| Inventory Turnover | 1.25 | 1.25 | 1.32 | 1.46 | 1.59 | 1.14 | Upgrade
|
| Quick Ratio | 5.26 | 5.26 | 6.28 | 6.52 | 6.16 | 8.04 | Upgrade
|
| Current Ratio | 7.74 | 7.74 | 8.61 | 8.75 | 7.87 | 10.73 | Upgrade
|
| Return on Equity (ROE) | 1.30% | 1.30% | 3.25% | 2.76% | 3.37% | 2.31% | Upgrade
|
| Return on Assets (ROA) | 0.57% | 0.57% | 1.70% | 1.66% | 2.15% | 1.53% | Upgrade
|
| Return on Invested Capital (ROIC) | 1.18% | 1.33% | 3.75% | 3.73% | 4.73% | 3.31% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.00% | 1.00% | 2.90% | 2.90% | 3.70% | 2.60% | Upgrade
|
| Earnings Yield | 0.84% | 1.03% | 1.95% | 1.38% | 1.75% | 1.25% | Upgrade
|
| FCF Yield | 1.87% | 2.30% | 2.70% | -0.18% | 2.64% | 1.00% | Upgrade
|
| Dividend Yield | 1.62% | - | 1.62% | 1.17% | 1.48% | 2.07% | Upgrade
|
| Payout Ratio | 202.09% | 202.09% | 69.91% | 99.17% | 107.46% | 162.39% | Upgrade
|
| Buyback Yield / Dilution | -1.60% | -1.60% | -0.07% | 0.04% | -0.05% | -0.01% | Upgrade
|
| Total Shareholder Return | 0.01% | -1.60% | 1.55% | 1.22% | 1.43% | 2.06% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.